Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma. - Schwark K; Wink K; De Cola A; Miclea M; Patel T; Kong S; Stanczak A; Doherty R; Pearson A; Murthy B; Lau B; Cartaxo RT; et al. (Research square, 2026)